4-cymene has been researched along with Breast Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Biswas, S; Chakraborty, S; Golding, TM; Omondi, RO; Prince, S; Smith, GS | 1 |
| Brabec, V; Kasparkova, J; Kostrhunova, H; Markova, L; Novohradsky, V; Trávníček, Z | 1 |
| Dömötör, O; Enyedy, ÉA; Frank, É; Gál, GT; Gašparović, AČ; Kiss, MA; May, NV; Nové, M; Spengler, G | 1 |
3 other study(ies) available for 4-cymene and Breast Neoplasms
| Article | Year |
|---|---|
Quinolyl-Based PGM Metallarectangles: Antiproliferative Activity, DNA and BSA Protein Interactions, and a Molecular Docking Perspective.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cisplatin; Coordination Complexes; DNA; Female; Humans; Ligands; MCF-7 Cells; Molecular Docking Simulation; Quinolines; Ruthenium; Serum Albumin, Bovine | 2023 |
An anticancer Os(II) bathophenanthroline complex as a human breast cancer stem cell-selective, mammosphere potent agent that kills cells by necroptosis.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chloroacetates; Coordination Complexes; Cymenes; Female; Humans; Necroptosis; Necrosis; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Organoplatinum Compounds; Osmium; Phenanthrolines; Tumor Microenvironment | 2019 |
Solution equilibrium, structural and cytotoxicity studies on Ru(η
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Proliferation; Coordination Complexes; Copper; Cymenes; Female; Humans; Liver Neoplasms; Organometallic Compounds; Pyrazoles; Ruthenium; Thiosemicarbazones; Tumor Cells, Cultured | 2020 |